BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38538275)

  • 1. The Role of Human Pluripotent Stem Cells in Amyotrophic Lateral Sclerosis: From Biological Mechanism to Practical Implications.
    Ceccarelli L; Verriello L; Pauletto G; Valente M; Spadea L; Salati C; Zeppieri M; Ius T
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):114. PubMed ID: 38538275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
    Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R
    Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease.
    Jaiswal MK
    Neural Regen Res; 2017 May; 12(5):723-736. PubMed ID: 28616022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis.
    Du H; Huo Z; Chen Y; Zhao Z; Meng F; Wang X; Liu S; Zhang H; Zhou F; Liu J; Zhang L; Zhou S; Guan Y; Wang X
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
    Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis.
    Nikel LM; Talbot K; Vahsen BF
    Bioessays; 2024 Jul; 46(7):e2400054. PubMed ID: 38713169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALS, a cellular whodunit on motor neuron degeneration.
    Karagiannis P; Inoue H
    Mol Cell Neurosci; 2020 Sep; 107():103524. PubMed ID: 32629110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Generation of Ready-to-Use Cryopreserved Motor Neurons from Human Pluripotent Stem Cells for Disease Modeling.
    Ting HC; Su HL; Chen MF; Harn HJ; Lin SZ; Chiou TW; Chang CY
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.
    Ichiyanagi N; Fujimori K; Yano M; Ishihara-Fujisaki C; Sone T; Akiyama T; Okada Y; Akamatsu W; Matsumoto T; Ishikawa M; Nishimoto Y; Ishihara Y; Sakuma T; Yamamoto T; Tsuiji H; Suzuki N; Warita H; Aoki M; Okano H
    Stem Cell Reports; 2016 Apr; 6(4):496-510. PubMed ID: 26997647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.
    Faravelli I; Riboldi G; Nizzardo M; Simone C; Zanetta C; Bresolin N; Comi GP; Corti S
    Cell Mol Life Sci; 2014 Sep; 71(17):3257-68. PubMed ID: 24699704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.
    Okano H; Morimoto S; Kato C; Nakahara J; Takahashi S
    J Neurochem; 2023 Dec; 167(5):603-614. PubMed ID: 37952981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Specific Cells for Modeling and Decoding Amyotrophic Lateral Sclerosis: Advances and Challenges.
    Zhao A; Pan Y; Cai S
    Stem Cell Rev Rep; 2020 Jun; 16(3):482-502. PubMed ID: 31916190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis.
    Seminary ER; Santarriaga S; Wheeler L; Mejaki M; Abrudan J; Demos W; Zimmermann MT; Urrutia RA; Fee D; Barkhaus PE; Ebert AD
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an Open-Access Patient-Derived iPSC Biobank for Amyotrophic Lateral Sclerosis Disease Modelling.
    Hedges EC; Cocks G; Shaw CE; Nishimura AL
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.